Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/46065| Title: | Acetylcholinesterase inhibitors for autistic spectrum disorders. | Authors: | Cox G.R.;Williams K.;Woon J.M.;Haslam R.;Ure A. | Institution: | (Williams, Ure) Developmental Paediatrics, Monash Children's Hospital, Melbourne, Australia (Cox, Williams, Ure) Department of Paediatrics, Monash University, Melbourne, Australia (Cox, Woon) Neurodevelopment and Disability, The Royal Children's Hospital, Melbourne, Australia (Haslam, Ure) Mental Health Department, The Royal Children's Hospital, Melbourne, Australia (Williams, Haslam) Department of Paediatrics, University of Melbourne, Melbourne, Australia (Williams, Ure) Murdoch Children's Research Institute, Melbourne, Australia |
Issue Date: | 28-Aug-2021 | Copyright year: | 2021 | Publisher: | John Wiley and Sons Ltd | Place of publication: | United Kingdom | Publication information: | Cochrane Database of Systematic Reviews. 2021(1) (no pagination), 2021. Article Number: CD013851. Date of Publication: 23 Jan 2021. | Journal: | Cochrane Database of Systematic Reviews | Abstract: | Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To evaluate the efficacy and harms of acetylcholinesterase inhibitors for individuals with the core features (social interaction, communication, and restrictive and repetitive behaviours) of ASD. Secondary objective This review will also assess the effects of acetylcholinesterase inhibitors on non-core features of ASD.Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. | DOI: | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1002/14651858.CD013851 | URI: | https://repository.monashhealth.org/monashhealthjspui/handle/1/46065 | Type: | Article | Subjects: | anxiety disorder attention deficit disorder *autism/dt [Drug Therapy] Autism Diagnostic Interview Revised Autism Diagnostic Observation Schedule automutilation behavior disorder Childhood Autism Rating Scale cholinergic system clinical outcome cognition comorbidity compulsion diarrhea/si [Side Effect] drug effect drug efficacy drug response drug safety DSM-5 DSM-IV fatigue/si [Side Effect] functional status gastrointestinal disease/si [Side Effect] health status ICD-10 interpersonal communication mental disease mood nausea/si [Side Effect] prevalence quality of life sleep disorder/si [Side Effect] social interaction urine incontinence/si [Side Effect] vomiting/si [Side Effect] acetylcholine *cholinesterase inhibitor/ae [Adverse Drug Reaction] *cholinesterase inhibitor/dt [Drug Therapy] donepezil/cm [Drug Comparison] donepezil/dt [Drug Therapy] donepezil/po [Oral Drug Administration] donepezil/td [Transdermal Drug Administration] galantamine/cm [Drug Comparison] galantamine/dt [Drug Therapy] galantamine/po [Oral Drug Administration] galantamine/td [Transdermal Drug Administration] rivastigmine/cm [Drug Comparison] rivastigmine/dt [Drug Therapy] rivastigmine/po [Oral Drug Administration] rivastigmine/td [Transdermal Drug Administration] restrictive behavior |
| Appears in Collections: | Articles |
Show full item record
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.